Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill

HIV cure still remains an elusive target. The “Shock and Kill” strategy which aims to reactivate HIV from latently infected cells and subsequently kill them through virally induced apoptosis or immune mediated clearance, is the subject of widespread investigation. NF-κB is a ubiquitous transcription...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular and infection microbiology Vol. 14; p. 1354502
Main Authors Chandrasekar, Aswath P., Maynes, Mark, Badley, Andrew D.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 05.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:HIV cure still remains an elusive target. The “Shock and Kill” strategy which aims to reactivate HIV from latently infected cells and subsequently kill them through virally induced apoptosis or immune mediated clearance, is the subject of widespread investigation. NF-κB is a ubiquitous transcription factor which serves as a point of confluence for a number of intracellular signaling pathways and is also a crucial regulator of HIV transcription. Due to its relatively lower side effect profile and proven role in HIV transcription, the non-canonical NF-κB pathway has emerged as an attractive target for HIV reactivation, as a first step towards eradication. A comprehensive review examining this pathway in the setting of HIV and its potential utility to cure efforts is currently lacking. This review aims to summarize non-canonical NF-κB signaling and the importance of this pathway in HIV shock-and-kill efforts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Amanda Robinson Panfil, The Ohio State University, United States
Reviewed by: Guochun Jiang, University of North Carolina at Chapel Hill, United States
Edited by: Ana Carolina Soares De Oliveira, University of São Paulo, Brazil
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2024.1354502